FINWIRES · TerminalLIVE
FINWIRES

Sila Realty Trust to be Taken Private by Blue Owl Affiliates in $2.4 Billion Deal

By

Sila Realty Trust (SILA) agreed to be acquired and taken private by certain affiliates of Blue Owl Capital's (OWL) real estate unit in an all-cash deal worth roughly $2.4 billion.

Shareholders of net lease real estate investment trust Sila will receive $30.38 per share, representing a 19% premium to the stock's closing price on Friday, the companies said Monday.

The transaction, which requires approval from Sila's shareholders, is anticipated to complete in the second or third quarter of this year. Upon completion, the company will be delisted from the New York Stock Exchange.

"The consummation of this transaction will provide significant and immediate realized benefit to our shareholders," Sila Chief Executive Michael Seton said in a statement.

Shares of Sila were up 19% in Monday trade. Asset manager Blue Owl rose 1%.

Sila, which is focused on investing in healthcare facilities, said its portfolio comprised 137 real estate properties and three undeveloped land parcels in the US as of end-March. Data on its website showed its portfolio includes 86 medical outpatient buildings, 25 inpatient rehabilitation facilities, and 26 surgical and specialty facilities.

"This transaction provides us with a compelling opportunity to acquire a scaled portfolio with durable cash flows and attractive long-term growth characteristics, while further expanding Blue Owl managed funds' exposure to an asset class and sector we view as both resilient and essential given its critical role in both society and the economy," Marc Zahr, co-president and global head of real assets at Blue Owl, said.

In February, Sila reported fourth-quarter adjusted funds from operations of $0.55 per share, up from $0.54 a year ago. Revenue rose to $50.7 million from $46.5 million.

Sila plans to pay up to two regular quarterly dividends ahead of deal completion.

Price: $30.44, Change: $+4.90, Percent Change: +19.19%

Related Articles

Wire

Top Cryptocurrencies Rise; Bitcoin Tops $77,000 Level

Major digital assets rose Friday, with Bitcoin (BTC-USD) exceeding the $77,000 level.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, rose 2.3% in the past 24 hours. The Nasdaq 100 gained 1.2%, the S&P 500 increased 1.1%, and the Dow Jones Industrial Average climbed up 1.8%.Bitcoin rose 2.8% to $77,353, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume surged 28.9% to $54.38 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, gained 3.2% to $2,430.XRP (XRP-USD) climbed 1.8%, BNB (BNB-USD) rose 0.8%, while Solana (SOL-USD) fell 0.7%. Dogecoin (DOGE-USD) increased 0.7%, and Cardano (ADA-USD) advanced 0.6%.The US 10-year Treasury yield stood at 4.242% at 3 p.m. ET Friday, down from 4.305% Thursday, while the five-year yield fell to 3.836% from 3.911%.The total market value of the cryptocurrency industry rose 2.4% in the past 24 hours to $2.61 trillion, with trading volume gaining 2.6% to $158.98 billion.Price: $77363.53, Change: $+2211.54, Percent Change: +2.94%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD
Wire

Zai Lab to Present Zoci Data From Ongoing Phase 1 Trial at AACR Annual Meeting

Zai Lab (ZLAB) said Friday data from its ongoing phase 1 trial of zocilurtatug pelitecan showed a 53.7% intracranial objective response rate in patients with small cell lung cancer and brain metastases.The findings, which showed that the zoci drug candidate triggers intracranial lesion regression and reduced tumor size, will be presented at the American Association for Cancer Research Annual Meeting in San Diego, according to a statement.The potential zoci drug conjugate also demonstrated a manageable safety profile, with most adverse events reported as low grade, the company said.The company's phase 1b/2 trial data also showcased antitumor activity in patients with extrapulmonary neuroendocrine carcinomas, with an objective response rate of 38.2%, according to the company.Price: $24.06, Change: $+0.56, Percent Change: +2.38%

$ZLAB
Wire

Market Chatter: Palantir Selected to Compete on New FAA AI Tool

Palantir Technologies (PLTR), Thales, and Air Space Intelligence were selected by the US Federal Aviation Administration to compete on a new artificial intelligence tool for air traffic management, Bloomberg reported Friday, citing a person familiar with the matter.The FAA has received $12.5 billion from Congress for the project but it needs about $20 billion more to complete the overhaul, according to the report.Palantir did not immediately respond to a request for comment by.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $147.00, Change: $+4.24, Percent Change: +2.97%

$PLTR